Found Cost Explained: What Drives the Monthly Total

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Understanding what you actually pay each month means taking a telehealth GLP-1 bill apart piece by piece. This independent review does that for readers researching Found cost. Browse the wider Peptides & GLP-1 education library.

Full head-to-head: PlexusDx vs Found →

This is editorial analysis from PlexusDx. We have no commercial tie to Found or its parent company, and no affiliate links or compensation are involved.

Rather than quote a single headline figure, this piece explains the components that build a monthly total, why those totals move so much, and where a genetic layer adds context that price alone cannot. Balanced framing, not a buying recommendation. As of April 2026.

What "cost" really covers

The number people picture as "the cost of Found" is rarely one line item. In subscription telehealth it is a bundle, and the bundle shifts depending on the compound, the tier, and how the medication is sourced. Reading the total as a single price hides the parts that actually drive it up or down.

The pieces that build a monthly total

Program or membership fee

Most programs charge for clinical access, ongoing follow-up, and coordination separately from the drug. This fee can be flat or folded into the total.

Medication cost

The compound itself, semaglutide, tirzepatide, or another agent, carries its own price that varies by dose and dispensing route.

Dispensing pathway

Whether the prescription goes to a retail pharmacy for an FDA-approved brand product or to a 503A compounding pharmacy meaningfully changes the total.

Why totals swing so widely

Published pricing for Found lives on Found's own website. Across the GLP-1 telehealth market, monthly totals as of April 2026 tend to land anywhere from roughly $200 to $700 or more, with wide variance driven by product choice, subscription tier, and branded-versus-compounded sourcing. Because those levers move independently, two people using the same service can pay very different amounts. Confirm current numbers on the brand's own site before committing, since they change often.

How the compound class shapes price

Cost is inseparable from pharmacology. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide sit at different points on the price map, and the trial programs behind them, STEP (semaglutide, NEJM 2021) and SURMOUNT (tirzepatide, NEJM 2022), describe the compounds rather than any pricing tier. Endpoints and populations differ; outcomes vary individually.

The cost factor a price tag never shows

No monthly total captures the genetic terrain a GLP-1 compound acts on. Variants in MC4R, a melanocortin receptor central to satiety, and TCF7L2, tied to glucose homeostasis, describe baseline biology no invoice reflects. These are pathway-level markers, not response predictions. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, including MC4R and TCF7L2 variants that shape your energy-balance and glucose-regulation baseline, turning a spend decision into an informed conversation with your provider.

PlexusDx pricing, stated plainly

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols with medication-therapy-management-led pricing: Semaglutide Injection at $189 per month, Tirzepatide Injection at $289 per month, and a Microdose option at a flat $129 per month. The genetic test is $298, or $99 for program members. The point is transparency: the number is visible before you invest, alongside the pathway context most programs leave out.

No affiliation: PlexusDx is independent of Found and holds no commercial relationship with the programs discussed here.

More from the PlexusDx library: What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist, and GLP 1 Drugs.

Disclaimer: This article is educational. PlexusDx is not affiliated with Found and compares approaches across the GLP-1 telehealth space, including its own Weight Management Protocols. The Precision Peptide Genetic Test examines how your genes influence peptide-related pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before starting any peptide protocol.

Frequently Asked Questions

What makes up the monthly cost of a program like Found?

Three parts drive it: the program or membership fee for clinical access, the medication itself, and the dispensing pathway. Whether the drug is a branded product from a retail pharmacy or a compounded preparation from a 503A pharmacy shifts the total, which is why a single quoted figure rarely tells the whole story.

Why do quoted GLP-1 telehealth totals range so much?

Because the levers move independently. Product choice, subscription tier, dose, and branded-versus-compounded sourcing each change the number, so market totals as of April 2026 span roughly $200 to $700 or more. Always verify current pricing on a brand's own site before you commit.

How does PlexusDx price its protocols?

PlexusDx uses medication-therapy-management-led pricing: Semaglutide Injection at $189 monthly, Tirzepatide Injection at $289 monthly, and a Microdose at a flat $129 monthly. The Precision Peptide Genetic Test is $298, or $99 for program members, so the cost is visible upfront.

Does the genetic test change what I pay for a compound?

No. It does not set or lower medication cost and does not predict drug response. It reads pathway-level variants such as MC4R and TCF7L2 that describe your baseline biology, adding upstream context to the spending decision rather than altering the price of any prescription.

Keep reading in the PlexusDx Education Hub. Browse Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.